Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 3/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | CASP1 | P29466 | 1/20 | 0.44 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.44 |
| ▸ | CASP7 | P55210 | 1/20 | 0.44 |
| ▸ | CASP3 | P42574 | 1/20 | 0.43 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.43 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.43 |
| ▸ | FYN | P06241 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30739117 | 1.00 | SMN1; SMN2 (0.47) | SMN1; SMN2RAB9AKDM4EALDH1A1HPGD | |
| SCHEMBL3826940 | 0.98 | SMN1; SMN2 (0.46) | SMN1; SMN2RAB9AKDM4EALDH1A1HPGD | |
| SCHEMBL14155785 | 0.83 | KDM4E (0.44) | SMN1; SMN2RAB9AKDM4EALDH1A1HPGD | |
| SCHEMBL23302375 | 0.79 | KDM4E (0.46) | SMN1; SMN2RAB9AKDM4EALDH1A1HPGD | |
| SCHEMBL29595709 | 0.77 | NPSR1 (0.53) | SMN1; SMN2RAB9AKDM4EHPGDL3MBTL1 | |
| SCHEMBL811160 | 0.77 | NPSR1 (0.53) | SMN1; SMN2RAB9AKDM4EHPGDL3MBTL1 | |
| SCHEMBL7427844 | 0.77 | KDM4E (0.48) | SMN1; SMN2RAB9AKDM4EALDH1A1HPGD | |
| SCHEMBL12727899 | 0.76 | KDM4E (0.52) | SMN1; SMN2RAB9AKDM4EALDH1A1HPGD | |
| SCHEMBL10408880 | 0.76 | KDM4E (0.52) | SMN1; SMN2RAB9AKDM4EALDH1A1HPGD | |
| SCHEMBL3822666 | 0.75 | SMN1; SMN2 (0.50) | SMN1; SMN2RAB9AKDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117304094-A | Synthesis method of 3-trifluoromethyl pyridine or 3-difluoro methyl pyridine compound | 瑞博(杭州)医药科技有限公司 | 2023-12-29 | — | — | CN | disclosed |
| EP-1349435-B1 | LUMINESCENT ELEMENT AND DISPLAY | CANON KK (JP) | 2018-06-06 | — | — | EP | disclosed |
| US-20170029535-A1 | REGULATION OF A CONTROLLED RADICAL POLYMERIZATION OF ACRYLATES BY LIGHT | DOW GLOBAL TECHNOLOGIES LLC | 2017-02-02 | — | — | US | disclosed |
| US-20170029535-A1 | REGULATION OF A CONTROLLED RADICAL POLYMERIZATION OF ACRYLATES BY LIGHT | DOW GLOBAL TECHNOLOGIES LLC | 2017-02-02 | — | — | US | disclosed |
| US-9081283-B2 | Spatial and temporal control of brush formation on surfaces | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-07-14 | — | — | US | disclosed |
| EP-2034000-B1 | Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds | DU PONT (US) | 2015-05-06 | — | — | EP | disclosed |
| US-9000157-B2 | Metallic compound and organic electroluminescence device comprising the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-04-07 | — | — | US | disclosed |
| US-20120032158-A1 | Charge transport compositions and electronic devices made with such compositions | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-02-09 | — | — | US | disclosed |
| US-8071975-B2 | Electronic devices made with electron transport and/or anti-quenching layers | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-12-06 | — | — | US | disclosed |
| US-20110184170-A1 | METALLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME | SAMSUNG ELECTRONICS CO., LTD (KR) | 2011-07-28 | — | — | US | disclosed |
| EP-1520452-A2 | ELECTRONIC DEVICES MADE WITH ELECTRON TRANSPORT AND/OR ANTI-QUENCHING LAYERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2005-04-06 | — | — | EP | disclosed |
| US-20050025996-A1 | Luminescence device, display apparatus and metal coordination compound | CANON KABUSHIKI KAISHA (JP) | 2005-02-03 | — | — | US | disclosed |
| US-6821646-B2 | CAPABLE OF PROVIDING A HIGH-EFFICIENCY LUMINESCENT STATE AT A HIGH BRIGHTNESS (OR LUMINANCE) FOR A LONG PERIOD WHILE MINIMIZING THE DETERIORATION IN LUMINESCENCE IN ENERGIZED STATE | CANON KABUSHIKI KAISHA (JP) | 2004-11-23 | — | — | US | disclosed |
| EP-1442094-A2 | ELECTROLUMINESCENT IRIDIUM COMPOUNDS HAVING RED-ORANGE OR RED EMISSION AND DEVICES MADE WITH SUCH COMPOUNDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2004-08-04 | — | — | EP | disclosed |
| US-20040066135-A1 | Electronic devices made with electron transport and/or anti-quenching layers | LG CHEM, LTD. (KR) | 2004-04-08 | — | — | US | disclosed |
| WO-2004006352-A2 | ELECTRONIC DEVICES MADE WITH ELECTRON TRANSPORT AND/OR ANTI-QUENCHING LAYERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2004-01-15 | — | — | WO | disclosed |
| US-20030096138-A1 | Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds | LG CHEM, LTD. (KR) | 2003-05-22 | — | — | US | disclosed |
| WO-2003040256-A2 | ELECTROLUMINESCENT IRIDIUM COMPOUNDS HAVING RED-ORANGE OR RED EMISSION AND DEVICES MADE WITH SUCH COMPOUNDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-05-15 | — | — | WO | disclosed |
| US-20020063516-A1 | Limuninescence device, display apparatus and metal coordination compound | CANON KABUSHIKI KAISHA (JP) | 2002-05-30 | — | — | US | disclosed |
| EP-1191612-A2 | Luminescence device, display apparatus and metal coordination compound | CANON KABUSHIKI KAISHA (JP) | 2002-03-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110184170-A1 | METALLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME | MT-CO1, ROS1, OXA1L | SMN1; SMN2 2190/4885RAB9A 782/4885KDM4E 3090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.